These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7130973

  • 21. Review of β-carboline and its derivatives as selective MAO-A inhibitors.
    Benny F, Kumar S, Jayan J, Abdelgawad MA, Ghoneim MM, Kumar A, Manoharan A, Susan R, Sudevan ST, Mathew B.
    Arch Pharm (Weinheim); 2023 Jul; 356(7):e2300091. PubMed ID: 37021551
    [Abstract] [Full Text] [Related]

  • 22. Carcinogenic tryptophan pyrolysis products potent inhibitors of type A monoamine oxidase and the platelet response to 5-hydroxytryptamine.
    Manabe S, Kanai Y, Ishikawa S, Wada O.
    J Clin Chem Clin Biochem; 1988 May; 26(5):265-70. PubMed ID: 3404091
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.
    May T, Greube A, Strauss S, Heineke D, Lehmann J, Rommelspacher H.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):308-17. PubMed ID: 8208308
    [Abstract] [Full Text] [Related]

  • 24. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee.
    Herraiz T, Chaparro C.
    Life Sci; 2006 Jan 18; 78(8):795-802. PubMed ID: 16139309
    [Abstract] [Full Text] [Related]

  • 25. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A, Esteban S, Sastre-Coll A, Moranta D, Asensio VJ, García-Sevilla JA.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):234-42. PubMed ID: 16061219
    [Abstract] [Full Text] [Related]

  • 26. The effect of tryptolines (1, 2, 3, 4-tetrahydro-beta-carbolines) on monoamine metabolism and the platelet aggregation response in human platelets.
    Youdim MB, Oppenheim B.
    Neuroscience; 1981 Aug 22; 6(4):801-10. PubMed ID: 7242917
    [No Abstract] [Full Text] [Related]

  • 27. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul 22; 18(4):793-802. PubMed ID: 7938567
    [Abstract] [Full Text] [Related]

  • 28. β-Carbolines found in cigarette smoke elevate intracranial self-stimulation thresholds in rats.
    Harris AC, Muelken P, LeSage MG.
    Pharmacol Biochem Behav; 2020 Nov 22; 198():173041. PubMed ID: 32926882
    [Abstract] [Full Text] [Related]

  • 29. Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine.
    MacInnes N, Handley SL.
    Br J Pharmacol; 2002 Mar 22; 135(5):1227-34. PubMed ID: 11877331
    [Abstract] [Full Text] [Related]

  • 30. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 22; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 31. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T, Aomine M.
    Res Commun Mol Pathol Pharmacol; 1979 Feb 22; 122-123():13-26. PubMed ID: 25022028
    [Abstract] [Full Text] [Related]

  • 32. [STUDIES OF THE EFFECT OF THE MONOAMINE OXIDASE (MAO) INHIBITING ACTION OF SOME GAMMA-CARBOLINE DERIVATIVES].
    NANTKA-NAMIRSKI P, KURZEPA S, DUSZKA J, KAZIMIERCZYK J, KIERYLOWICZ H.
    Acta Physiol Pol; 1965 Feb 22; 16():131-9. PubMed ID: 14338598
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.